Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaokui Mo

Showing results (171-180 of 207) with videos related to

Pageof 21
Sort By:
Molecular Cancer Therapeutics|January 27, 2016
Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple MyelomaAndrew Stiff, Enrico Caserta, Douglas W Sborov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2016
IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor CellsElizabeth L McMichael, Alena Cristina Jaime-Ramirez, Kristan D Guenterberg, et al.
International Journal of Radiation Oncology, Biology, Physics|February 22, 2024
A Phase 2 Trial of Primary Tumor Stereotactic Body Radiation Therapy Boost Before Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung CancerTerence M Williams, Eric Miller, Meng Welliver, et al.
Blood Advances|August 23, 2021
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemiaEileen Y Hu, Priscilla Do, Swagata Goswami, et al.
Mabs|July 26, 2013
Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignanciesSarwish Rafiq, Anthony Siadak, Jonathan P Butchar, et al.
JCSM Communications|July 14, 2025
Intramuscular CMT-167 Tumors Produce a Mild Cachexia Phenotype in C57BL/6J MiceBryan C Remaily, Trang T Vu, Justin Thomas, et al.
Science Translational Medicine|January 28, 2026
SREBP-1 increases glucose uptake to promote tumor resistance to lysosome inhibitionYaogang Zhong, Feng Geng, Huali Su, et al.
Blood|March 26, 2016
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blastsSumithira Vasu, Shun He, Carolyn Cheney, et al.
Blood|October 5, 2012
Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemiaRosa Lapalombella, Qingxiang Sun, Katie Williams, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|November 26, 2020
An unexpected paradox: wall shear stress in the aorta is less in patients with severe atherosclerosis regardless of obesityShahzeb Qaisar, Leon D Brodsky, Rolf F Barth, et al.
Pageof 21

Showing results (171-180 of 207) with videos related to

Sort By:
Pageof 21
Molecular Cancer Therapeutics|January 27, 2016
Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple MyelomaAndrew Stiff, Enrico Caserta, Douglas W Sborov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2016
IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor CellsElizabeth L McMichael, Alena Cristina Jaime-Ramirez, Kristan D Guenterberg, et al.
International Journal of Radiation Oncology, Biology, Physics|February 22, 2024
A Phase 2 Trial of Primary Tumor Stereotactic Body Radiation Therapy Boost Before Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung CancerTerence M Williams, Eric Miller, Meng Welliver, et al.
Blood Advances|August 23, 2021
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemiaEileen Y Hu, Priscilla Do, Swagata Goswami, et al.
Mabs|July 26, 2013
Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignanciesSarwish Rafiq, Anthony Siadak, Jonathan P Butchar, et al.
JCSM Communications|July 14, 2025
Intramuscular CMT-167 Tumors Produce a Mild Cachexia Phenotype in C57BL/6J MiceBryan C Remaily, Trang T Vu, Justin Thomas, et al.
Science Translational Medicine|January 28, 2026
SREBP-1 increases glucose uptake to promote tumor resistance to lysosome inhibitionYaogang Zhong, Feng Geng, Huali Su, et al.
Blood|March 26, 2016
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blastsSumithira Vasu, Shun He, Carolyn Cheney, et al.
Blood|October 5, 2012
Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemiaRosa Lapalombella, Qingxiang Sun, Katie Williams, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|November 26, 2020
An unexpected paradox: wall shear stress in the aorta is less in patients with severe atherosclerosis regardless of obesityShahzeb Qaisar, Leon D Brodsky, Rolf F Barth, et al.
Pageof 21